Followers | 604 |
Posts | 24107 |
Boards Moderated | 3 |
Alias Born | 12/06/2009 |
Sunday, October 08, 2017 4:42:28 PM
PATENT: Splitting gp41
https://www.google.com/patents/WO2010089402A1?cl=en&dq=virosomes+mymetics&hl=en&sa=X&ved=0ahUKEwi_q7XuuYjWAhWG7SYKHWS1Cnk4ChDoAQhBMAQ
PATENT: Compositions and methods for the generation of protective immune response against malaria
https://www.google.com/patents/WO2004078099A2?cl=en&dq=virosomes+mymetics&hl=en&sa=X&ved=0ahUKEwi_q7XuuYjWAhWG7SYKHWS1Cnk4ChDoAQg6MAM
PATENT: Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines
https://www.google.com/patents/US7569541?dq=virosomes+mymetics&hl=en&sa=X&ved=0ahUKEwi_q7XuuYjWAhWG7SYKHWS1Cnk4ChDoAQglMAA
PATENT: Virosome-like-particles
https://www.google.com/patents/EP1594466A1?cl=en&dq=virosomes+mymetics&hl=en&sa=X&ved=0ahUKEwjQ0KXOuYjWAhUCbSYKHW6CC_oQ6AEIUjAG
PATENT: Virosome-like vesicles comprising gp41-derived antigens
https://www.google.com/patents/WO2007099446A3?cl=en&dq=virosomes+mymetics&hl=en&sa=X&ved=0ahUKEwjQ0KXOuYjWAhUCbSYKHW6CC_oQ6AEILTAB
PATENT: Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby
https://www.google.com/patents/WO2016039619A1?cl=en&dq=virosomes+mymetics&hl=en&sa=X&ved=0ahUKEwjQ0KXOuYjWAhUCbSYKHW6CC_oQ6AEIJjAA
PATENT: Novel gp41 antigens
https://www.google.com/patents/WO2010089400A1?cl=en&dq=virosomes+mymetics&hl=en&sa=X&ved=0ahUKEwi_q7XuuYjWAhWG7SYKHWS1Cnk4ChDoAQhIMAU
PATENT: New soluble and stabilized trimeric form of gp41 polypeptides
https://www.google.com/patents/WO2005010033A1?cl=en&dq=virosomes+mymetics&hl=en&sa=X&ved=0ahUKEwialJKtvIjWAhUF6SYKHVgXC3w4FBDoAQhdMAg
PATENT: Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines ]
https://www.google.com/patents/CA2527795C?cl=en&dq=virosomes+mymetics&hl=en&sa=X&ved=0ahUKEwialJKtvIjWAhUF6SYKHVgXC3w4FBDoAQhkMAk
PATENT: Functionally reconstituted viral membranes containing adjuvant
https://www.google.com/patents/EP1633395A1?cl=en&dq=virosomes+mymetics
Mymetics completes acquisition of Bestewil Holding B.V., Virosome Biologicals B.V. from Norwood Immunology - Quick Facts
4/9/2009 11:50 AM ET
Mymetics Corp. (MYMX.OB) announced that the company has completed the acquisition of Bestewil Holding B.V. and its subsidiary, Virosome Biologicals B.V., from Norwood Immunology Ltd. (NIM.L) as per the terms of the LOI described in the form 8-k filed on March 5, 2009.
MORE PATENTS FROM BESTEWIL:
https://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Bestewil+Holding+B.V.%22
PATENTS W/ MARIO AMACKER
https://www.google.com/search?hl=en&biw=1314&bih=771&tbm=pts&q=mario+amacker&oq=mario+amacker&gs_l=psy-ab.3..0i22i30k1l2.15192.17215.0.17430.13.13.0.0.0.0.362.1526.7j4j0j1.12.0....0...1.1.64.psy-ab..1.12.1522...0j0i131k1.z68k-SqdfA0
PATENTS W/ TOON STEGMANN
https://www.google.com/search?hl=en&biw=1314&bih=771&tbm=pts&q=toon+stegmann&oq=toon+stegm&gs_l=psy-ab.3.0.0i22i30k1l3.33580.35085.0.36555.10.10.0.0.0.0.316.1245.7j2j0j1.10.0....0...1.1.64.psy-ab..0.10.1239...0j0i131k1j0i67k1j0i10k1.GP6rA7is2ds
$MYMX
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM